Kairos PharmaKAPA
13F holders, Q2 2025 (June 30)10holders +2
5new positions
3sold out
$0.79avg. 13F price*
At the end of Q2 2025, 10 institutions reported holding Kairos Pharma Ltd. (KAPA) in their 13F filings, up 2 from Q1 2025. 5 opened new positions and 3 sold out. The largest holders were SevenBridge Financial Group, LLC ($50K), XTX Topco Ltd ($44K) and Aptus Capital Advisors, LLC ($31K).
- Company
- Kairos Pharma Ltd.
- CUSIP
- 48301N104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $70K |
| Exits | 3 | $1.4M |
All 13F filers, Q1 2025 → Q2 2025: 106,903 shares bought and 1,465,428 shares sold, net −1,358,525 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| SevenBridge Financial Group, LLC | 0.01% | No change | 44,286 | $50K |
| XTX Topco Ltd | 0.00% | New | 62,746 | $44K |
| Aptus Capital Advisors, LLC | 0.00% | No change | 44,286 | $31K |
| Geode Capital Management, LLC | 0.00% | Add +6.7% | 21,804 | $15K |
| Two Sigma Securities, LLC | 0.00% | New | 13,555 | $10K |
| HRT Financial LP | 0.00% | New | 13,239 | $9K |
| UBS Group AG | 0.00% | Add +238.8% | 9,458 | $7K |
| Citigroup Inc. | 0.00% | New | 5,499 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,797 | $3K |
| Bank of America Corp. | 0.00% | Add +142.9% | 51 | $36 |
"% of holder's portfolio" is KAPA's weight in each manager's 13F, not the share of Kairos Pharma Ltd. the manager owns.